Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine and Kidilact probiotic for oropharyngeal microflora in intubated ICU patients
IRCT20170316033099N9Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetylcysteine in Oropharyngeal colonization (3 arms), sponsored by Islamic Azad University. Primary endpoint: Microflora diversity. Started Jul 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Oropharyngeal colonization
Beyond the preview
Go deeper on IRCT20170316033099N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170316033099N9.